Severe Lactic Acidosis Complicated by Insulin-Resistant Hyperosmolar Hyperglycemic Syndrome in a Patient With Metastatic Breast Cancer Undergoing AKT-Inhibitor Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Severe Lactic Acidosis Complicated by Insulin-Resistant Hyperosmolar Hyperglycemic Syndrome in a Patient With Metastatic Breast Cancer Undergoing AKT-Inhibitor Therapy

Published:2022-06 Issue:6 Volume: Page:
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Stamou Maria I.¹^ORCID,Chen Christopher²^ORCID,Wander Seth A.³,Supko Jeffrey G.⁴^ORCID,Juric Dejan⁴^ORCID,Bardia Aditya³^ORCID,Wexler Deborah J.⁵⁶^ORCID

Affiliation:

1. Endocrine Division, Massachusetts General Hospital, Boston, MA

2. Department of Medicine, Stanford University School of Medicine,Palo Alto, CA

3. Division of Medical Oncology, Massachusetts General Hospital, Boston, MA

4. Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA

5. Harvard Medical School, Boston, MA

6. Diabetes Unit, Massachusetts General Hospital, Boston, MA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.21.00428

Reference36 articles.

1. TOR, a Central Controller of Cell Growth

2. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

3. Complications of hyperglycaemia with PI3K–AKT–mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials

4. A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors

5. Pharmacokinetics of Ipatasertib in Subjects With Hepatic Impairment Using 2 Methods of Classification of Hepatic Function

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin/ipatasertib;Reactions Weekly;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3